Proteome Sciences plc (LON:PRM – Get Free Report) dropped 9.8% on Wednesday . The stock traded as low as GBX 3.18 ($0.04) and last traded at GBX 3.18 ($0.04). Approximately 41,420 shares changed hands during trading, a decline of 55% from the average daily volume of 91,685 shares. The stock had previously closed at GBX 3.52 ($0.04).
Proteome Sciences Stock Performance
The stock has a market cap of £14.17 million, a P/E ratio of -480.00 and a beta of 0.07. The firm has a 50 day moving average of GBX 2.92 and a two-hundred day moving average of GBX 3.11.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Further Reading
- Five stocks we like better than Proteome Sciences
- What Are Dividend Champions? How to Invest in the Champions
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Learn Technical Analysis Skills to Master the Stock Market
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
